TherapeuticsMD, Inc.
TXMD Nasdaq
SEC CIK 25743
Follow TherapeuticsMD
Weekly email: filings, results, news
Revenue, last quarter
$869K
−8.7% vs same quarter last year
Net income
$155K
−71.9% vs same quarter last year
EPS, diluted
$0.01
−80% vs same quarter last year
Operating cash flow
$779K
+104.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $3M | −$569K |
| FY24 | $1.8M | −$2.2M |
| FY23 | $1.3M | −$10.3M |
| FY22 | $70M | $112M |
| FY21 | $2.6M | −$172.4M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −145.3% | −18.8% |
| FY24 | - | −347.1% | −123.9% |
| FY23 | 100% | −654.6% | −789.4% |
| FY22 | 98% | 1.7% | 160.1% |
| FY21 | 45.5% | −3092.8% | −6700.9% |
- TherapeuticsMD
- Healthcare median
Show the numbers
| Year | TherapeuticsMD | Healthcare median |
|---|---|---|
| FY25 | −18.8% | 9.8% |
| FY24 | −123.9% | 10.5% |
| FY23 | −789.4% | 5.3% |
| FY22 | 160.1% | 12.7% |
| FY21 | −6700.9% | 10.8% |
News
No stories filed under TherapeuticsMD yet - coverage appears here as the news feed clusters it.